FIELD: biotechnology.
SUBSTANCE: disclosed is a set of polynucleotides for producing an isolated antigen-binding polypeptide structure, as well as a set of expression vectors, an isolated host cell and a method for producing an antigen-binding polypeptide structure.
EFFECT: group of inventions enables to obtain antigen-binding polypeptide constructs based on antibodies, having high stability.
29 cl, 12 dwg, 35 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONSTRUCTED PAIRS OF HEAVY-LIGHT CHAINS OF IMMUNOGLOBULIN AND USE THEREOF | 2013 |
|
RU2826203C1 |
| CONSTRUCTED PAIRS OF HEAVY-LIGHT IMMUNOGLOBULIN CHAINS AND THEIR USE | 2013 |
|
RU2720472C2 |
| ANTIGEN-BINDING POLYPEPTIDE CONSTRUCTS CONTAINING KAPPA AND LAMBDA LIGHT CHAINS, AND APPLICATIONS THEREOF | 2016 |
|
RU2824193C2 |
| LY6G6D ANTIBODIES AND METHODS OF USE | 2020 |
|
RU2818569C1 |
| MOLECULES THAT BIND BCMA AND USE OF SUCH MOLECULES | 2019 |
|
RU2812322C2 |
| ANTIBODY THAT BINDS TO VEGF AND IL-1BETA, AND METHODS OF USE THEREOF | 2019 |
|
RU2816476C2 |
| ANTIBODIES TO LAG3 | 2018 |
|
RU2778053C2 |
| ANTIBODIES TO CD38 AND COMBINATIONS WITH ANTIBODIES TO CD3 AND CD28 | 2018 |
|
RU2812910C2 |
| METHODS OF TREATING CANCER USING ANTAGONISTS BINDING TO COMPONENTS OF THE SIGNAL PATH PD-1, AND TAXANES | 2014 |
|
RU2719487C2 |
| BISPECIFIC ANTIBODIES TO CCL2 | 2020 |
|
RU2819613C1 |
